[go: up one dir, main page]

SE9300105D0 - Stable protein solution - Google Patents

Stable protein solution

Info

Publication number
SE9300105D0
SE9300105D0 SE9300105A SE9300105A SE9300105D0 SE 9300105 D0 SE9300105 D0 SE 9300105D0 SE 9300105 A SE9300105 A SE 9300105A SE 9300105 A SE9300105 A SE 9300105A SE 9300105 D0 SE9300105 D0 SE 9300105D0
Authority
SE
Sweden
Prior art keywords
pct
igf
mmol
formulation
relates
Prior art date
Application number
SE9300105A
Other languages
English (en)
Inventor
E Florin-Robertsson
J Fransson
D Widegran
Original Assignee
Kabi Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kabi Pharmacia Ab filed Critical Kabi Pharmacia Ab
Priority to SE9300105A priority Critical patent/SE9300105D0/sv
Publication of SE9300105D0 publication Critical patent/SE9300105D0/sv
Priority to PCT/SE1994/000010 priority patent/WO1994015584A1/en
Priority to AT94905282T priority patent/ATE177942T1/de
Priority to NZ259951A priority patent/NZ259951A/en
Priority to AU58939/94A priority patent/AU676882B2/en
Priority to CA002153787A priority patent/CA2153787C/en
Priority to JP51592294A priority patent/JP3580816B2/ja
Priority to DK94905282T priority patent/DK0679079T3/da
Priority to ES94905282T priority patent/ES2131673T3/es
Priority to DE69417397T priority patent/DE69417397T2/de
Priority to EP94905282A priority patent/EP0679079B1/en
Priority to US08/491,902 priority patent/US5783559A/en
Priority to GR990401477T priority patent/GR3030383T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/30—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
SE9300105A 1993-01-15 1993-01-15 Stable protein solution SE9300105D0 (sv)

Priority Applications (13)

Application Number Priority Date Filing Date Title
SE9300105A SE9300105D0 (sv) 1993-01-15 1993-01-15 Stable protein solution
US08/491,902 US5783559A (en) 1993-01-15 1994-01-10 Solution containing IGF-1
AU58939/94A AU676882B2 (en) 1993-01-15 1994-01-10 Solution containing IGF-1
AT94905282T ATE177942T1 (de) 1993-01-15 1994-01-10 Lösung, die igf-1 enthält
NZ259951A NZ259951A (en) 1993-01-15 1994-01-10 Stable solutions of insulin-like growth factor and phosphate buffer
PCT/SE1994/000010 WO1994015584A1 (en) 1993-01-15 1994-01-10 Solution containing igf-1
CA002153787A CA2153787C (en) 1993-01-15 1994-01-10 Solution containing igf-1
JP51592294A JP3580816B2 (ja) 1993-01-15 1994-01-10 インシュリン状成長因子を含有する安定溶液
DK94905282T DK0679079T3 (da) 1993-01-15 1994-01-10 Opløsning indeholdende IGF-1
ES94905282T ES2131673T3 (es) 1993-01-15 1994-01-10 Solucion que contiene igf-1.
DE69417397T DE69417397T2 (de) 1993-01-15 1994-01-10 Lösung, die igf-1 enthält
EP94905282A EP0679079B1 (en) 1993-01-15 1994-01-10 Solution containing igf-1
GR990401477T GR3030383T3 (en) 1993-01-15 1999-06-01 Solution containing igf-1.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9300105A SE9300105D0 (sv) 1993-01-15 1993-01-15 Stable protein solution

Publications (1)

Publication Number Publication Date
SE9300105D0 true SE9300105D0 (sv) 1993-01-15

Family

ID=20388550

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9300105A SE9300105D0 (sv) 1993-01-15 1993-01-15 Stable protein solution

Country Status (12)

Country Link
US (1) US5783559A (sv)
EP (1) EP0679079B1 (sv)
JP (1) JP3580816B2 (sv)
AT (1) ATE177942T1 (sv)
AU (1) AU676882B2 (sv)
DE (1) DE69417397T2 (sv)
DK (1) DK0679079T3 (sv)
ES (1) ES2131673T3 (sv)
GR (1) GR3030383T3 (sv)
NZ (1) NZ259951A (sv)
SE (1) SE9300105D0 (sv)
WO (1) WO1994015584A1 (sv)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9502927D0 (sv) * 1995-08-24 1995-08-24 Pharmacia Ab Solution containing IGF-I
RU2179034C2 (ru) * 1996-09-13 2002-02-10 Транскариотик Терапиз, Инк. ЛЕЧЕНИЕ В СЛУЧАЕ ДЕФИЦИТА α-ГАЛАКТОЗИДАЗЫ А
US6767892B1 (en) 1997-11-07 2004-07-27 Chrion Corporation Compositions providing for increased IGF-I solubility
ATE238807T1 (de) * 1997-11-07 2003-05-15 Chiron Corp Zusammensetzung um die löslichkeit von igf-i zu erhöhen
BR9917606A (pt) 1998-11-06 2002-12-31 Bio Sidus S A Procedimento para a purificação de eritropoetina humana recombinante a partir de sobrenadantes de cultivo de células e eritropoetina humana recombinante obtida com tal procedimento
UY25790A1 (es) * 1998-11-06 2000-08-21 Bio Sidus S A Formas farmaceuticas de eritropoyetina humana recombinante estables a temperatura ambiente y apropiadas para su uso en humanos, formulaciones y procedimientos de liofilizacion para su obtencion.
US6777205B1 (en) 1998-11-06 2004-08-17 Sterrenbeld Biotechnologie North America, Inc. Host cells expressing recombinant human erythropoietin
BR9905868A (pt) 1998-11-06 2001-01-23 Bio Sidus S A Procedimento de cultivo massivo de células de mamìfero para a obtenção de eritropoetina humana, recombinante e a eritropoetina humana recombinante obtida com tal procedimento
PT1165119E (pt) 1999-04-08 2004-02-27 Genentech Inc Composicao baseada em polipeptidos com cargas opostas
JP2001233787A (ja) * 2000-02-04 2001-08-28 Patents Exploitation Co Bv 小・中サイズのペプチド含有薬学的組成物
ES2615484T3 (es) 2002-05-21 2017-06-07 Daiichi Sankyo Company, Limited Composiciones medicinales que contienen grelina
KR101149454B1 (ko) 2004-08-24 2012-05-25 간가와 겐지 생리활성 펩티드의 액상 제제
US20110152188A1 (en) * 2009-12-23 2011-06-23 Hanns-Christian Mahler Pharmaceutical compositions of igf/i proteins
EP3811962A4 (en) * 2018-06-25 2022-03-16 JCR Pharmaceuticals Co., Ltd. PROTEIN AQUEOUS LIQUID FORMULATION

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4853224A (en) * 1987-12-22 1989-08-01 Visionex Biodegradable ocular implants
DE3939346A1 (de) * 1989-11-29 1991-06-06 Behringwerke Ag Arzneimitel zur subkutanen oder intramuskulaeren applikation enthaltend polypeptide
US5126324A (en) * 1990-06-07 1992-06-30 Genentech, Inc. Method of enhancing growth in patients using combination therapy
DE4126983A1 (de) * 1991-08-15 1993-02-18 Boehringer Mannheim Gmbh Verfahren zur herstellung von humanprotein-enthaltenden, konservierten arzneimitteln fuer infusions- oder injektionszwecke

Also Published As

Publication number Publication date
EP0679079B1 (en) 1999-03-24
EP0679079A1 (en) 1995-11-02
US5783559A (en) 1998-07-21
AU676882B2 (en) 1997-03-27
WO1994015584A1 (en) 1994-07-21
ATE177942T1 (de) 1999-04-15
DK0679079T3 (da) 1999-10-11
DE69417397D1 (de) 1999-04-29
JP3580816B2 (ja) 2004-10-27
AU5893994A (en) 1994-08-15
JPH08505617A (ja) 1996-06-18
DE69417397T2 (de) 1999-09-09
ES2131673T3 (es) 1999-08-01
GR3030383T3 (en) 1999-09-30
NZ259951A (en) 1996-10-28

Similar Documents

Publication Publication Date Title
SE9300105D0 (sv) Stable protein solution
JPS6471818A (en) Storage-stable and tolerable human protein medicine and manufacture
EP1201241B8 (en) Compositions containing capsaicin or capsaicin analogues and an anesthetic
HK1107103A1 (en) Purification and stabilization of peptide and proteins in pharmaceutical agents
KR910007542A (ko) 폴리펩타이드의 서방형 조성물
DE69531741D1 (de) Verbindungen und zusammensetzungen zur verabreichung aktiver stoffe
DE336200T1 (de) Piroxicam in waessrigen loesungen enthaltende arzneizubereitungen und verfahren zu deren herstellung.
ATE95522T1 (de) Verfahren zur herstellung von des-b30-insulinen und des-b30-insulinderivaten.
BR9506840A (pt) Preparação farmacêutica contendo ativadores de plasminogênio
Nanninga et al. Role of magnesium and calcium in the first and second contraction of glycerin-extracted muscle fibers
DE60043994D1 (de) Stabile wässrige formulierung von interferon, präparationsmethode und dessen verwendung
ATE291918T1 (de) Kombinationstherapie zur behandlung von tumoren
ATE205399T1 (de) Eine lagerstabile wässrige lösung zur infusion die einen thrombininhibitor enthält
DE69231036D1 (de) Verfahren zur behandlung von patienten mit chronischer lebererkrankung
GB9503750D0 (en) Thrombin preparation
CA2153787A1 (en) Solution containing igf-1
ATE241387T1 (de) Verfahren zur in vivo dns-verabreichung durch verwendung eines nadelfreien geräts
JP2001187750A (ja) 感染部位検知方法、それに使用する組成物およびその組成物の製造方法
EP0717625A4 (en) METHOD FOR TREATING LIVER DISEASES AND SIMILAR INDICATIONS WITH VASODILATING ACTIVE SUBSTANCES
CA2165271A1 (en) Reduction of adipose tissue
UA43413C2 (uk) Спосіб одержання ін'єкційного засобу "ерихрозид" для лікування серцево-судинних захворювань
ATE72397T1 (de) Pharmazeutische zusammensetzungen zur behandlung von hyperproliferativer hautkrankheit.
UA29106A (uk) Спосіб лікування вібраційної хвороби